LynxCare raises €20M in Series A funding

On 21 June 2022, LynxCare announced a €20M round of Series A funding, which is the largest Series A round in Belgian digital health history. The funding round was led by the Swiss HealthTech Investor MTIP, joined by Elaia (FR), alongside early-stage investors Heran (BE), BtoV Partners (DE) and PMV (BE). This funding round will allow LynxCare to accelerate their international rollout and support of the team’s growth. 

LynxCare was proudly assisted by Filip Lecoutre, Nils Vermeulen and Ludovic Meeus. Our team was involved in all legal aspects of this Series A funding and led the negotiations for LynxCare.

About LynxCare 

LynxCare is a big data specialist in healthcare, providing an AI-powered data platform that collects and analyses structured and unstructered clinical data for improved patient care and accelerated scientific research. Trough AI and language processing data-driven technology, LynxCare is leading an evolution towards value- and outcome- based healthcare to benefit patients, doctors, care providers and hospitals, while rigorously applying ethical standards and data protection legislation. 

Founded by Georges De Feu and Dries Hens in 2015, LynxCare today is a fast-growing Belgian scale-up company, employing around 35 people, unlocking clinical data across Europe and North-America.